We are live on ! Find out more
VSTM icon

Verastem

86 hedge funds and large institutions have $201M invested in Verastem in 2015 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 37 increasing their positions, 16 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

331% more call options, than puts

Call options by funds: $1.09M | Put options by funds: $254K

156% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 9

131% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 16

47% more capital invested

Capital invested by funds: $137M → $201M (+$63.8M)

19% more funds holding

Funds holding: 7286 (+14)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
86
Holders Change
+14
Holders Change %
+19.44%
% of All Funds
2.28%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
23
Increased
37
Reduced
16
Closed
9
Calls
$1.09M
Puts
$254K
Net Calls
+$841K
Net Calls Change
+$841K

VSTM Hedge Fund Activity: Q1 2015 in Review

86 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in Verastem (VSTM) for Q1 2015, worth a combined $201M — up 47% from $137M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new VSTM positions and 9 closed out — a net gain of 14 holders — while 37 added to existing stakes and 16 trimmed.

The largest buyer was Broadfin Capital, opening a new position worth an estimated $9.17M. The largest seller was JP Morgan Chase, cutting an estimated $4.18M.

  • 86 institutional investors held Verastem (VSTM) as of Q1 2015, up from 72 in Q4 2014.
  • Funds reported $201M of Verastem stock for Q1 2015, up 47% quarter-over-quarter.
  • 23 funds opened new Verastem positions in Q1 2015 and 9 closed out, a net change of +14 holders.
  • The largest Verastem buyer in Q1 2015 was Broadfin Capital, an estimated $9.17M added.
  • The largest Verastem seller in Q1 2015 was JP Morgan Chase, an estimated $4.18M sold.

Based on aggregated 13F filings for Q1 2015.